Advertisement
In Brief

A. Samer Al-Homsi named system chief of blood and marrow transplant and cellular therapy at Northwell

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

A. Samer Al-Homsi, a leader in hematology, was appointed as system chief of blood and  marrow transplant and cellular therapy at the Northwell Health Cancer Institute. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In Brief

José Larios joins Karmanos Cancer Institute’s BMT and hematology multidisciplinary teams

José Larios, a transplant hematologist, joined The Barbara Ann Karmanos Cancer Institute as a member of the bone marrow and stem cell transplant and hematology oncology multidisciplinary teams at Karmanos. He specializes in treating leukemia and lymphoma blood cancers, including Hodgkin and non-Hodgkin lymphomas. He began seeing patients at the Karmanos Cancer Center in Detroit in August 2024.
In Brief

Northwell invests $1.2M to develop program to treat tumors with noninvasive targeted ultrasound beams

Marking a new era of non-invasive medical interventions, the Northwell Health Cancer Institute is investing $1.2 million in the development of cutting-edge histotripsy technology to treat some liver cancer tumors without surgery. This innovative approach uses targeted ultrasound beams to create microbubbles within tumors, effectively disrupting and destroying diseased cells without the need for incisions.
Advertisement
Advertisement